Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway.

Frontiers in oncology·2020

Same author

Pranoprofen Nanoparticles With <i>Poly</i>(L-<i>Lactide</i>)-b-<i>Poly</i>(<i>Ethylene Glycol</i>)-<i>b-Poly</i>(L-<i>Lactide</i>) as the Matrix Toward Improving Ocular Anti-inflammation.

Frontiers in bioengineering and biotechnology·2020

Same author

A Systematic Review of Youth and Teen Mental Health First Aid: Improving Adolescent Mental Health.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2020

Same author

Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible role in preeclampsia.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2020

Same author

Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn's disease: a randomised, controlled, open-label trial.

BMJ open·2020

Same author

Role of modern neoadjuvant chemoradiotherapy in locally advanced thymic epithelial neoplasms.

Tumori·2020

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Prospective strategies for targeting HIV-1 integrase function.

Yang Luo¹, Mark A Muesing

¹Aaron Diamond AIDS Research Center, 455 1st Avenue, New York, NY 10016, USA.

Future Medicinal Chemistry

|March 2, 2011

Summary

Future HIV-1 therapies could target integrase's first catalytic step, '3' processing,' and other essential functions. Blocking viral DNA integration prevents irreversible HIV infection, offering new treatment strategies beyond current strand transfer inhibitors.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Related Experiment Videos

Last Updated: Jun 4, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Area of Science:

Virology
Molecular Biology
Drug Discovery

Background:

Human Immunodeficiency Virus type 1 (HIV-1) integration into host DNA is essential for viral replication.
HIV-1 integrase protein mediates viral DNA integration through two catalytic steps: 3' processing and strand transfer.
Current HIV-1 therapies primarily target the strand transfer step, leaving 3' processing and other integrase functions unexplored for therapeutic intervention.

Purpose of the Study:

To explore novel therapeutic strategies targeting the early catalytic step (3' processing) of HIV-1 integrase.
To investigate nonenzymatic functions of HIV-1 integrase that are critical for viral replication.
To identify new targets for preventing irreversible HIV-1 infection.

Main Methods:

This review outlines theoretical and potential experimental strategies.
Focuses on the enzymatic and non-enzymatic roles of HIV-1 integrase.
Discusses the potential for targeting 3' processing and other integrase-dependent steps.

Main Results:

The 3' processing step is a viable target for novel antiviral agents.
Inhibiting integrase's nonenzymatic functions could also impede viral replication.
Targeting integration offers a late-stage intervention point to prevent infection.

Conclusions:

Developing drugs that target HIV-1 integrase's 3' processing offers a promising avenue for new antiviral therapies.
Interfering with integrase's diverse functions, beyond strand transfer, can effectively block HIV-1 replication.
Targeting the integration step represents a critical opportunity to prevent the establishment of irreversible HIV-1 infection.